Briefing
Histone modifications define distinct nucleosome positions in cell-free DNA
This bioRxiv preprint reports modification-associated nucleosome positions in cell-free DNA, identified by cfChIP-seq in plasma from patients with prostate cancer. In targeted panels, a 50-locus model distinguished samples with tumor fraction of 3% or more from tumor-fraction-zero samples (AUC 0.91-0.96 across prostate, breast, and lung datasets). This is a preprint, not a peer-reviewed clinical MRD study, and the reported threshold is a tumor fraction of 3%.
- Design: Evidence level 3
- Assay: Not named in the abstract